To inspire and empower millions of people living with Parkinson’s around the world, Bial launches a touching campaign for the World Parkinson’s Day showing that it is possible to live a normal life, and successfully perform everyday tasks
Imagine being unable to control your own body. In your mind, everything is exactly like it was; but your brain seems to have forgotten how to tell your body to do everyday tasks like tying up shoes or using a toothbrush.
This is how it feels to live with Parkinson’s. A real challenge for the 10 million people diagnosed with Parkinson’s around the world. Parkinson’s is a progressive neurodegenerative disease – an illness that affects nerve cells in the brain. For those who live with these symptoms and for their families, Parkinson’s means much more than just physical symptoms: it also means a loss of their independence.
In order to raise awareness and help people keep their self-esteem, people with Parkinson’s were invited to star in a video that shows them at their best by focusing on what they can do instead of what they cannot do. Buttoning up shirts, putting on make-up, tying up shoes or even dancing and playing musical instruments. Simple, everyday tasks alongside a cheerful, feel-good tune developed specially for the campaign.
António Portela, CEO of Bial, explains the positive tone of the campaign: “Parkinson’s can really change people’s lives, but it’s very important that they do not lose their self-esteem. That is why we wanted to counter the negative portraits of people with Parkinson’s and show everyone what they really can do. Hopefully, we can inspire and empower the millions of people living with Parkinson’s to never give up on their dignity. Bial’s aim is to help the lives of people with Parkinson’s even if it’s to help with one small thing at a time.”
The campaign launches worldwide today – on World Parkinson’s Day – and is featured on Bial’s website, across Bial’s social media and on the European Parkinson’s Disease Association’s social media channels too.
Watch the video ‘Me at my best’ below
This article is sponsored by Bial. The information in this article is given for information purposes only and does not represent an endorsement by the EPDA of any particular treatments, products or companies. This article is not a substitute for advice from your doctor, pharmacist or other healthcare professional. Parkinson’s Life makes no representations or warranties of any kind, express or implied, about the completeness or accuracy of information provided.
Founded in 1924, Bial’s mission is to discover, develop and provide therapeutic solutions within the area of health. In recent decades, Bial has strategically focused on quality, innovation and internationalisation. Bial has channelled more than 20% of its annual turnover into research and development within neurosciences and the cardiovascular system.
In 2016 Bial launched Opicapone for Parkinson’s disease. Already available in Germany and in the United Kingdom, it will be introduced in the remaining European countries throughout 2017.
Currently representing around two thirds of its turnover, Bial will continue to strengthen its international presence based in its own innovative medicines, particularly in the most important European pharmaceutical markets, Spain, Germany, United Kingdom and Italy, where the company is already present with its own affiliates. For more information about Bial, please visit www.bial.com.
Researchers at Helsinki University Hospital, Finland, have found that the overuse of antibiotic drugs could increase the risk of developing Parkinson’s. The study – published in medical journal ‘Movement Disorders’ – compared data on antibiotic exposure in 13,976 people with Parkinson’s and 40,697 people without. The researchers found that overuse of some antibiotic drugs can cause Parkinson’s, that it can take up to 15 years before any symptoms emerge – and that the connection to Parkinson’s could be due to the drug’s effects on the gut. Filip Scheperjans, neurologist and lead researcher of the study, said: “The link between antibiotic exposure and Parkinson’s disease fits the current view that in a significant proportion of patients the pathology of Parkinson’s may originate in the gut, possibly related to microbial changes, years before the onset of typical Parkinson’s symptoms such as slowness, muscle stiffness and shaking of the extremities.”
New Parkinson’s health app to track symptoms more accurately
Health app SleepFit could be used to track Parkinson’s symptoms in real time, providing clinicians with a more accurate view of patients’ condition, according to a new study. As part of the research – published in ‘Journal of Parkinson’s Disease’ – 42 people with Parkinson’s recorded their symptoms on the app four times a day for a period of two weeks. After the study, to test the data against patients’ own recollection of their symptoms, those participating completed a questionnaire – recording symptoms such as walking difficulty and hand dexterity. The results showed that 16.7% of those who took part tended to over or underestimate their symptoms when completing the questionnaire, therefore providing inaccurate information. Dr Pietro Luca Ratti, lead researcher of the study, said: “The importance of accurately assessing motor symptoms is pivotal in the clinical follow-up of patients with Parkinson’s Disease.”